Erratum: Jeter JM, Bowles TL, Curiel‐Lewandrowski C, Et Al. Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials. Cancer . 2019:125:18‐44.

Cancer - United States
doi 10.1002/cncr.32075
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials

Cancer
Cancer ResearchOncology
2018English

Erratum: Brian Et Al. (2019)

Adapted Physical Activity Quarterly
Physical TherapySports TherapyRehabilitationSports Science
2019English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Surrogate Endpoint Biomarkers for Cervical Cancer Chemoprevention Trials

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
1995English

Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials

Clinics in Geriatric Medicine
GerontologyGeriatrics
2011English

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2017English

Criteria for Implementation of Large and Multiagent Clinical Chemoprevention Trials

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2000English

Ethics in Clinical Trials : Ethical Standards in Phase 1 Trials of Neuroprotective Agents for Stroke Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1998English

Chemoprevention of Melanoma

Current Challenges in Personalized Cancer Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy